<SEC-DOCUMENT>0001193125-21-241153-index.html : 20210810
<SEC-HEADER>0001193125-21-241153.hdr.sgml : 20210810
<ACCEPTANCE-DATETIME>20210810071259
ACCESSION NUMBER:		0001193125-21-241153
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20210810
FILED AS OF DATE:		20210810
DATE AS OF CHANGE:		20210810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Achilles Therapeutics plc
		CENTRAL INDEX KEY:			0001830749
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40299
		FILM NUMBER:		211158406

	BUSINESS ADDRESS:	
		STREET 1:		245 HAMMERSMITH ROAD
		CITY:			LONDON
		STATE:			X0
		ZIP:			W6 8PW
		BUSINESS PHONE:		44 (0)20 8154 4600

	MAIL ADDRESS:	
		STREET 1:		245 HAMMERSMITH ROAD
		CITY:			LONDON
		STATE:			X0
		ZIP:			W6 8PW

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Achilles Therapeutics Ltd
		DATE OF NAME CHANGE:	20201030
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d202347d6k.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: d202347d6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d202347dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: d202347dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d202347dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 3 - file: d202347dex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>d202347dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
Document 4 - file: d202347dex993.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g202347dsp6.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g202347dsp6.gif

</DOCUMENT>
</SEC-DOCUMENT>